Category Archives : Allgemein

Home  >>  Allgemein

Roche: FDA approves Foundation Medicine’s FoundationOne CDx, the first pan-tumour comprehensive genomic profiling assay incorporating a broad range of companion diagnostics

On Dezember 7, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Roche: FDA approves Foundation Medicine’s FoundationOne CDx, the first pan-tumour comprehensive genomic profiling assay incorporating a broad range of companion diagnostics

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved FoundationOne CDx™, Foundation Medicine’s comprehensive companion diagnostic assay for personalised oncology care1. FoundationOne CDx supports physicians in clinical decision-making by providing a report that describes the unique genomic profile of the patient’s…

BGI AND HUMMINGBIRD DIAGNOSTICS SIGN MEMORANDUM OF UNDERSTANDING

On Dezember 7, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für BGI AND HUMMINGBIRD DIAGNOSTICS SIGN MEMORANDUM OF UNDERSTANDING

Collaboration in miRNA-based molecular diagnostic applications for neurodegenerative disorders SHENZHEN, HEIDELBERG, December 6, 2017 – BGI, one of the world’s leading genomics organisations, headquartered in Shenzhen, Guangdong, P. R. China, and Hummingbird Diagnostics GmbH, Heidelberg, Germany, an innovator in miRNA-based diagnostic tests from blood for early disease detection, today announced…

DKFZ: Protective human anti-malarial antibodies induced by natural parasite exposure.

On November 30, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ: Protective human anti-malarial antibodies induced by natural parasite exposure.

No effective vaccine exists to date against the tropical disease malaria. Scientists from the German Cancer Research Center (DKFZ) have now studied how the human immune system responds to natural infection by the malaria parasite. Analyzing individual immune cells, they discovered that the immune system produces antibodies that are protective…

EMBL: 2 EMBL researchers awarded prestigious ERC grants

On November 28, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für EMBL: 2 EMBL researchers awarded prestigious ERC grants

Takashi Hiiragi and Lars Steinmetz received Advanced Grants from the European Research Council (ERC) Two EMBL group leaders have joined a long list of EMBL principle investigators to receive prestigious ERC grants to support research in their labs. Takashi Hiiragi, a group leader in the Developmental Biology Unit in Heidelberg…

Hummingbird Diagnostics GmbH and Saarland University Collaborate in Early Disease Detection Based on Molecular Markers

On November 14, 2017, Posted by , In Allgemein,News,Press Releases, With Kommentare deaktiviert für Hummingbird Diagnostics GmbH and Saarland University Collaborate in Early Disease Detection Based on Molecular Markers

miRNA Experts Sign Framework Agreement HEIDELBERG and SAARBRÜCKEN, November 14, 2017 – Hummingbird Diagnostics GmbH, specialized in early disease detection using molecular markers derived from blood, and Saarland University agreed on a comprehensive framework agreement regarding an expanded collaboration in the field of molecular diagnostics. The work aims at the…

BioRN Annual Conference 2017 – Joint Forces for Future Innovations

On November 10, 2017, Posted by , In Allgemein,Press Releases, With Kommentare deaktiviert für BioRN Annual Conference 2017 – Joint Forces for Future Innovations

During the BioRN Annual Conference 2017 on October 24, titled “Revolution through Convolution – combining medtech, biotech and digital health to promote health science in our region”, about 120 participants came together from the BioRN Cluster and from the national and international life-science industry, among them representatives of the “Health…

TRANSVAC: European Vaccine Research and Development Infrastructure

On Oktober 17, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für TRANSVAC: European Vaccine Research and Development Infrastructure

TRANSVAC is a new infrastructure project – funded by the European Commission in the context of Horizon 2020 – that aims to accelerate the development of effective vaccines urgently needed to address European and global health challenges with the ultimate goal  to build an efficient and sustainable collaboration of experts…

Train – Pitch- Meet – Training and Selection of Europe’s best Biotech Startups

On Oktober 12, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Train – Pitch- Meet – Training and Selection of Europe’s best Biotech Startups

Train – Pitch- Meet – Training and Selection of Europe’s best Biotech Startups International Biotech Semifinal of the European Health Catapult Heidelberg, 12 October 2017 On October 4-6, BioRN, together with EIT Health, organized the Biotech Semifinal of the European Health Catapult. The Biotech semifinal consisted of two training days…

EMBL: Looping the loops: How chromosomes form

On Oktober 11, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für EMBL: Looping the loops: How chromosomes form

EMBL researchers and collaborators take important steps in unravelling chromosome formation The nucleus of a human cell is less than one hundredth of a millimetre across but the DNA inside it – if stretched out – would be around two metres long. To fit into such a small space, the…

Apogenix Granted Orphan Designation by the European Commission for Asunercept to Treat Myelodysplastic Syndromes

On Oktober 11, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Apogenix Granted Orphan Designation by the European Commission for Asunercept to Treat Myelodysplastic Syndromes

Orphan designations facilitate the development and authorization of medicines for rare diseases, as assessed by the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products  Heidelberg, Germany, October 05, 2017 – Apogenix AG, a biopharmaceutical company developing next-generation immuno-oncology therapeutics, announced today that its lead product candidate, asunercept (APG101), has…